Insider · CIK 0001972527
Zurit Levine
Files at CGEN (COMPUGEN LTD). First filing Mar 30, 2026, latest Jul 13, 2026.
In brief
Zurit Levine files SEC Form 4 as officer at CGEN (COMPUGEN LTD). Since Mar 30, 2026, Zurit Levine has reported 0 open-market buys worth $0 and 8 open-market sells worth $83k, the latest filed on Jul 13, 2026.
A track record needs three past buys with six months of prices behind them; Zurit Levine has 0, so none is measured yet.
The newest scored trade: sold $4,688 of CGEN on Jul 9, 2026, filed Jul 13, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 8 sells worth $83k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGEN: COMPUGEN LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | COMPUGEN LTD | $4,688 1,875 shares | -6% | +86% from low-20% from high | |
| 0Weak | COMPUGEN LTD | $6,400 2,000 shares | -6% | +148% from low0% from high | |
| 0Weak | COMPUGEN LTD | $5,600 2,000 shares | -6% | +130% from low0% from high | |
| 0Weak | COMPUGEN LTD | $8,013 3,125 shares | -10% | +113% from low0% from high | |
| 0Weak | COMPUGEN LTD | $8,013 3,125 shares | -10% | +113% from low0% from high | |
| 0Weak | COMPUGEN LTD | $19k 7,875 shares | -25% | +97% from low-2% from high | |
| 0Weak | COMPUGEN LTD | $7,700 3,500 shares | -11% | +86% from low-7% from high | |
| 0Weak | COMPUGEN LTD | $24k 11,875 shares | -29% | +75% from low-13% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 27, 2026 | CGEN COMPUGEN LTD | 4,000 0.00% of outstanding | $12k | Apr 24, 2026 | $64k |
| Apr 15, 2026 | CGEN COMPUGEN LTD | 2,000 0.00% of outstanding | $5,520 | Apr 14, 2026 | $59k |
| Apr 13, 2026 | CGEN COMPUGEN LTD | 2,000 0.00% of outstanding | $4,960 | Apr 10, 2026 | $53k |
| Mar 26, 2026 | CGEN COMPUGEN LTD | 24,375 0.03% of outstanding | $50k | Mar 26, 2026 | none |
Transactions
Every row this insider has filed, 37 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Ordinary Shares | +18,000 | $0.00 | $0 | 47,375 | Jul 30, 2026 |
| Jul 29, 2026 | CGEN COMPUGEN LTD | AGrant or award Share Option (right to buy)derivative | +24,000 | $0.00 | $0 | 24,000 | Jul 30, 2026 |
| Jul 9, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +1,875 | $0.83 | $1,555 | 31,250 | Jul 13, 2026 |
| Jul 9, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -1,875 | $2.50 | $4,688 | 29,375 | Jul 13, 2026 |
| Jul 9, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -1,875 | $0.00 | $0 | 3,750 | Jul 13, 2026 |
| Apr 24, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,000 | $1.15 | $2,300 | 31,375 | Apr 27, 2026 |
| Apr 24, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -2,000 | $3.20 | $6,400 | 29,375 | Apr 27, 2026 |
| Apr 24, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 52,000 | Apr 27, 2026 |
| Apr 14, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,000 | $1.15 | $2,300 | 31,375 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +1,125 | $0.83 | $933 | 30,500 | Apr 15, 2026 |
| Apr 14, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -2,000 | $2.80 | $5,600 | 29,375 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,000 | $1.15 | $2,300 | 32,500 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -3,125 | $2.56 | $8,013 | 29,375 | Apr 15, 2026 |
| Apr 14, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 54,000 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -1,125 | $0.00 | $0 | 5,625 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 56,000 | Apr 15, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +1,125 | $0.83 | $933 | 30,500 | Apr 13, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,000 | $1.15 | $2,300 | 32,500 | Apr 13, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -3,125 | $2.56 | $8,013 | 29,375 | Apr 13, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -1,125 | $0.00 | $0 | 5,625 | Apr 13, 2026 |
| Apr 10, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,000 | $0.00 | $0 | 56,000 | Apr 13, 2026 |
| Apr 7, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,500 | $0.83 | $2,073 | 31,875 | Apr 9, 2026 |
| Apr 7, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -2,500 | $2.30 | $5,750 | 29,375 | Apr 9, 2026 |
| Apr 8, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +4,375 | $0.83 | $3,628 | 33,750 | Apr 9, 2026 |
| Apr 8, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +1,000 | $1.15 | $1,150 | 34,750 | Apr 9, 2026 |
| Apr 8, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -5,375 | $2.42 | $13k | 29,375 | Apr 9, 2026 |
| Apr 7, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 11,125 | Apr 9, 2026 |
| Apr 8, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -4,375 | $0.00 | $0 | 6,750 | Apr 9, 2026 |
| Apr 8, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 58,000 | Apr 9, 2026 |
| Apr 1, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +2,500 | $0.83 | $2,073 | 31,875 | Apr 3, 2026 |
| Apr 1, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +1,000 | $1.15 | $1,150 | 32,875 | Apr 3, 2026 |
| Apr 1, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -3,500 | $2.20 | $7,700 | 29,375 | Apr 3, 2026 |
| Apr 1, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 13,625 | Apr 3, 2026 |
| Apr 1, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 59,000 | Apr 3, 2026 |
| Mar 26, 2026 | CGEN COMPUGEN LTD | MOption exercise Ordinary Shares10b5-1 | +11,875 | $0.83 | $9,847 | 41,250 | Mar 30, 2026 |
| Mar 26, 2026 | CGEN COMPUGEN LTD | SOpen-market sale Ordinary Shares10b5-1 | -11,875 | $2.04 | $24k | 29,375 | Mar 30, 2026 |
| Mar 26, 2026 | CGEN COMPUGEN LTD | MOption exercise Share Option (right to buy)derivative10b5-1 | -11,875 | $0.00 | $0 | 16,125 | Mar 30, 2026 |
Questions about Zurit Levine
Answered from the filings on this page, as of the latest one.
Is Zurit Levine buying or selling?
In the last 12 months Zurit Levine reported 0 open-market buys worth $0 and 8 open-market sells worth $83k on SEC Form 4; the latest was sold $4,688 of CGEN on Jul 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Zurit Levine's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Zurit Levine has 0.
Where does Zurit Levine file Form 4?
Zurit Levine has filed Form 4 at CGEN (COMPUGEN LTD) as SVP, Business Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.